Editas Medicine, Inc.EDITNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+69.5%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+69.5%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
14x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 60.45% |
| 2024 | -48.45% |
| 2023 | 25.12% |
| 2022 | -16.98% |
| 2021 | -43.24% |
| 2020 | 4.32% |
| 2019 | -23.91% |
| 2018 | 5.17% |
| 2017 | -23.40% |
| 2016 | -175.23% |